Lippo Village, Tangerang, Indonesia
Thursday, February 8, 2018
PT Siloam International Hospitals Tbk (“Siloam”) today held the topping-off ceremony for Siloam General Hospital Kelapa Dua (“RSUS KD”) in Tangerang. Tangerang City officials, Siloam officials and residence of Kelapa Dua gathered as H. Ahmad Zaki Iskandar, B.Bus, Regent of Tangerang, place the last stone to mark the completion of the building. Joining them for the ceremony were DR. James T. Riady, Chief Executive Officer of Lippo Group; and Prof. Dr. Dr. dr. Eka Julianta Wahjoepramono, SpBS, Dean of University of Pelita Harapan Faculty of Medicine. Free cholesterol; blood sugar; and uric acid test was offered to the attendees in order to celebrate this milestone.
Set to open in Q2 2018, the 200 bed hospital is modelled after Pavilion B of Siloam Hospitals Lippo Village, also known as Siloam General Hospital Lippo Village (“RSUS LV”). Just like its predecessor, RSUS KD will provide round the clock care for BPJS Kesehatan patients. The hospital will be equipped with 64 slices CT-Scan to assist the doctor in making the diagnosis more accurately. RSUS KD will provide more than 10 branch of specializations such as paediatric, obstetrics and gynaecology, neurology, ophthalmologist and dentistry.
DR. James T. Riady stated, “In accordance with the vision of Siloam: International Quality, Scale, Reach and Godly Compassion, we hope the presence of RSUS KD is not only as our support for government programs to nourish the nation but also to provide access to modern and affordable healthcare that bring a positive impact for the people of Tangerang and its surroundings.”
Ketut Budi Wijaya, President Director of Siloam stated, "Now the last stone is in place and with the support from Tangerang City officials, we are confident this hospital will be operational in Q2 2018. The opening of RSUS KD will be the testimony of Siloam’s commitment to serve all patients regardless of their socioeconomic status. Additionally, RSUS KD and RSUS LV will set example on successful Public-Private Partnerships where the government and private institution work on a common goal to bring positive impact to the community. Being the first private owned BPJS focused general hospital in the area, RSUS KD will give better access to international quality health care for more than 100,000 people residing in the area.”
Siloam is a subsidiary of PT Lippo Karawaci Tbk (“LPKR”), the largest listed property company in Indonesia by total assets and revenues, anchored by a large land bank and solid recurring income base. LPKR's businesses comprise Residential/Township, Retail Malls, Hospitals, Hotels and Asset Management.
Siloam now operates 32 hospitals in 23 cities throughout the country receiving more than 2 million visits & admissions and carrying out more than 41,000 surgeries every year. The 6,500 beds capacities are supported by about 2,700 specialists and general practitioners as well as over 9,800 nurses and support staff. It also manages the first JCI accredited hospital in Indonesia and a repeat winner of “Frost & Sullivan, Indonesia’s Healthcare Service Provider of the Year”. Siloam is listed on the Indonesian Stock Exchange under the ticker name “SILO” and a market capitalization of Rp 14.1 trillion or USD 1,038.9 million as of February 7, 2018.
For more information, please contact:
Anastasia Trivena Haliem
Investor Relations Manager
Siloam Hospitals Group
[email protected]
Disclaimer:
This press release has been prepared by PT Siloam International Hospitals Tbk (“Siloam”) and is circulated for the purpose of general information only. It is not intended for any specific person or purpose and does not constitute a recommendation regarding the securities of Siloam. No warranty (expressed or implied) is made to the accuracy or completeness of the information. All opinions and estimations included in this release constitute our judgment as of this date and are subject to change without prior notice. Siloam disclaims any responsibility or liability whatsoever arising which may be brought against or suffered by any person as a result of reliance upon the whole or any part of the contents of this press release and neither Siloam nor any of its affiliated companies and their respective employees and agents accepts liability for any errors, omissions, negligent or 3 otherwise, in this press release and any inaccuracy herein or omission here from which might otherwise arise.
Forward-Looking Statements. Certain statements in this release are or may be forward- looking statements. These statements typically contain words such as "will", "expects" and "anticipates" and words of similar import. By their nature, forward looking statements involve a number of risks and uncertainties that could cause actual events or results to differ materially from those described in this release. Factors that could cause actual results to differ include, but are not limited to, economic, social and political conditions in Indonesia; the state of the healthcare industry in Indonesia; prevailing market conditions; increases in regulatory burdens in Indonesia, including environmental regulations and compliance costs; fluctuations in foreign currency exchange rates; interest rate trends, cost of capital and capital availability; the anticipated demand and selling prices for our healthcare and related capital expenditures and investments; the cost of construction; availability of healthcare; competition from other companies and venues; shifts in customer demands; changes in operation expenses, including employee wages, benefits and training, governmental and public policy changes; our ability to be and remain competitive; our financial condition, business strategy as well as the plans and objectives of our management for future operations; generation of future receivables; and environmental compliance and remediation. Should one or more of these uncertainties or risks, among others, materialize, actual results may vary materially from those estimated, anticipated or projected. Specifically, but without limitation, capital costs could increase, projects could be delayed and anticipated improvements in production, capacity or performance might not be fully realized. Although we believe that the expectations of our management as reflected by such forward-looking statements are reasonable based on information currently available to us, no assurances can be given that such expectations will prove to have been correct. You should not unduly rely on such statements. In any event, these statements speak only as of the date hereof, and we undertake no obligation to update or revise any of them, whether as a result of new information, future events or otherwise.
